Human Abuse Potential
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Assessment of Abuse Potential of Cebranopadol in Humans (NCT05256108) | Tris Pharma, Inc. | 2022-03-28 |
| Assessment of Abuse Potential of Rapastinel in Humans (NCT03799900) | Naurex, Inc, an affiliate of Allergan plc | 2018-11-01 |
Track Human Abuse Potential automatically
Every clearance here is in the API, with alerts when new ones post.